Cite
HARVARD Citation
Ackerman, S. et al. (n.d.). 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. Journal for immunotherapy of cancer. p. A638. [Online].